NEW DELHI, Aug 25: Eris Lifesciences on Monday said one of its manufacturing units in Ahmedabad has received approval from Brazil’s national health regulatory agency ANVISA.
The approval follows a successful inspection conducted by the agency in May 2025, and enables the drugmaker to enter Brazil, the largest pharmaceutical market in South America, Eris Lifesciences said in a statement.
Shares of the company were trading 0.2 per cent up at Rs 1,772.50 apiece on BSE. (PTI)
Follow our WhatsApp channel
